• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于广义修正 Weibull 分布的混合和非混合治愈分数模型及其在胃癌数据中的应用。

Mixture and non-mixture cure fraction models based on the generalized modified Weibull distribution with an application to gastric cancer data.

机构信息

Department of Social Medicine, University of São Paulo (USP), Ribeirão Preto School of Medicine, Brazil.

出版信息

Comput Methods Programs Biomed. 2013 Dec;112(3):343-55. doi: 10.1016/j.cmpb.2013.07.021. Epub 2013 Aug 6.

DOI:10.1016/j.cmpb.2013.07.021
PMID:24008248
Abstract

The cure fraction models are usually used to model lifetime time data with long-term survivors. In the present article, we introduce a Bayesian analysis of the four-parameter generalized modified Weibull (GMW) distribution in presence of cure fraction, censored data and covariates. In order to include the proportion of "cured" patients, mixture and non-mixture formulation models are considered. To demonstrate the ability of using this model in the analysis of real data, we consider an application to data from patients with gastric adenocarcinoma. Inferences are obtained by using MCMC (Markov Chain Monte Carlo) methods.

摘要

治愈分率模型通常用于对存在长期幸存者的寿命时间数据进行建模。在本文中,我们介绍了在存在治愈分率、删失数据和协变量的情况下,对四参数广义修正 Weibull(GMW)分布的贝叶斯分析。为了包含“治愈”患者的比例,我们考虑了混合和非混合配方模型。为了演示在分析实际数据时使用此模型的能力,我们考虑了一个来自胃腺癌患者数据的应用。通过使用 MCMC(马尔可夫链蒙特卡罗)方法进行推断。

相似文献

1
Mixture and non-mixture cure fraction models based on the generalized modified Weibull distribution with an application to gastric cancer data.基于广义修正 Weibull 分布的混合和非混合治愈分数模型及其在胃癌数据中的应用。
Comput Methods Programs Biomed. 2013 Dec;112(3):343-55. doi: 10.1016/j.cmpb.2013.07.021. Epub 2013 Aug 6.
2
The exponentiated exponential mixture and non-mixture cure rate model in the presence of covariates.带协变量时的指数指数混合和非混合治愈率模型。
Comput Methods Programs Biomed. 2013 Oct;112(1):114-24. doi: 10.1016/j.cmpb.2013.06.015. Epub 2013 Aug 9.
3
Bayesian mixture cure rate frailty models with an application to gastric cancer data.贝叶斯混合治愈率脆弱性模型及其在胃癌数据中的应用。
Stat Methods Med Res. 2021 Mar;30(3):731-746. doi: 10.1177/0962280220974699. Epub 2020 Nov 26.
4
Bayesian bivariate generalized Lindley model for survival data with a cure fraction.具有治愈比例的生存数据的贝叶斯双变量广义林德利模型
Comput Methods Programs Biomed. 2014 Nov;117(2):145-57. doi: 10.1016/j.cmpb.2014.07.011. Epub 2014 Aug 1.
5
Cure fraction estimation from the mixture cure models for grouped survival data.基于分组生存数据的混合治愈模型的治愈分数估计
Stat Med. 2004 Jun 15;23(11):1733-47. doi: 10.1002/sim.1774.
6
Utilization of a Mixture Cure Rate Model based on the Generalized Modified Weibull Distribution for the Analysis of Leukemia Patients.基于广义修正 Weibull 分布的混合治愈率模型在白血病患者分析中的应用。
Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1045-1053. doi: 10.31557/APJCP.2021.22.4.1045.
7
A Bayesian long-term survival model parametrized in the cured fraction.一个以治愈比例为参数的贝叶斯长期生存模型。
Biom J. 2009 Jun;51(3):443-55. doi: 10.1002/bimj.200800199.
8
Inferences for Weibull Fréchet Distribution Using a Bayesian and Non-Bayesian Methods on Gastric Cancer Survival Times.贝叶斯和非贝叶斯方法在胃癌生存时间中的威布尔-弗雷歇分布推断。
Comput Math Methods Med. 2021 May 26;2021:9965856. doi: 10.1155/2021/9965856. eCollection 2021.
9
Semiparametric Bayesian estimation of quantile function for breast cancer survival data with cured fraction.具有治愈比例的乳腺癌生存数据分位数函数的半参数贝叶斯估计
Biom J. 2016 Sep;58(5):1164-77. doi: 10.1002/bimj.201500111. Epub 2016 May 10.
10
Application of the Bayesian dynamic survival model in medicine.贝叶斯动态生存模型在医学中的应用。
Stat Med. 2010 Feb 10;29(3):347-60. doi: 10.1002/sim.3795.

引用本文的文献

1
Cost-effectiveness of atezolizumab plus bevacizumab versus sorafenib as first-line therapy in unresectable hepatocellular carcinoma in the US and Chinese setting: a modelling comparison study.在美国和中国背景下,阿替利珠单抗联合贝伐单抗与索拉非尼作为不可切除肝细胞癌一线治疗的成本效益:一项建模比较研究。
BMJ Open. 2025 Mar 6;15(3):e094804. doi: 10.1136/bmjopen-2024-094804.
2
Long-Term Survival of Patient with End-Stage Renal Disease Using Bayesian Mixture Cure Rate Frailty Models.使用贝叶斯混合治愈率脆弱模型的终末期肾病患者的长期生存情况
Iran J Public Health. 2024 Sep;53(9):2113-2120. doi: 10.18502/ijph.v53i9.16464.
3
A generalized Gompertz promotion time cure model and its fitness to cancer data.
一种广义的冈珀茨促癌时间治愈模型及其对癌症数据的拟合
Heliyon. 2024 Jun 1;10(11):e32038. doi: 10.1016/j.heliyon.2024.e32038. eCollection 2024 Jun 15.
4
The estimation of long and short term survival time and associated factors of HIV patients using mixture cure rate models.利用混合治愈率模型估计 HIV 患者的长期和短期生存时间及相关因素。
BMC Med Res Methodol. 2023 May 22;23(1):123. doi: 10.1186/s12874-023-01949-x.
5
Cost-effectiveness of sintilimab plus chemotherapy versus chemotherapy alone as first-line treatment of locally advanced or metastatic oesophageal squamous cell carcinoma.信迪利单抗联合化疗对比单纯化疗作为局部晚期或转移性食管鳞癌一线治疗的成本效果分析。
Front Immunol. 2023 Jan 23;14:1092385. doi: 10.3389/fimmu.2023.1092385. eCollection 2023.
6
A bimodal Weibull distribution: properties and inference.双峰威布尔分布:性质与推断
J Appl Stat. 2021 May 24;49(12):3044-3062. doi: 10.1080/02664763.2021.1931822. eCollection 2022.
7
The new Neyman type A generalized odd log-logistic-G-family with cure fraction.具有治愈分数的新型奈曼A型广义奇对数逻辑斯蒂-G族
J Appl Stat. 2021 May 3;49(11):2805-2824. doi: 10.1080/02664763.2021.1922994. eCollection 2022.
8
Laplacian-P-splines for Bayesian inference in the mixture cure model.拉普拉斯样条在混合治愈模型中贝叶斯推断的应用。
Stat Med. 2022 Jun 30;41(14):2602-2626. doi: 10.1002/sim.9373. Epub 2022 Mar 14.
9
Short-term and long-term survival of patients with gastric cancer.胃癌患者的短期和长期生存情况。
Gastroenterol Hepatol Bed Bench. 2021 Spring;14(2):115-122.
10
Utilization of a Mixture Cure Rate Model based on the Generalized Modified Weibull Distribution for the Analysis of Leukemia Patients.基于广义修正 Weibull 分布的混合治愈率模型在白血病患者分析中的应用。
Asian Pac J Cancer Prev. 2021 Apr 1;22(4):1045-1053. doi: 10.31557/APJCP.2021.22.4.1045.